| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |